Related Experiment Video

Updated: Oct 6, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

Biotransformation, estrogenicity, and steroid structure as determinants of dysmorphogenic and generalized embryotoxic

B K Beyer1, K L Stark, A G Fantel

  • 1Department of Pharmacology School of Medicine University of Washington, Seattle 98195.

Toxicology and Applied Pharmacology
|March 15, 1989
PubMed

Insights

Embryonic development is altered by various chemicals, with effects depending on how the body metabolizes them, not just their estrogenic strength. This research highlights the crucial role of biotransformation in chemical embryotoxicity.

Area of Science:

  • Developmental toxicology
  • Embryology
  • Biochemistry

Background:

  • Maternal factors can confound studies on chemical effects on embryonic development.
  • Estrogenic and non-estrogenic chemicals can impact embryonic growth and organogenesis.
  • Understanding direct chemical effects on embryos is crucial for risk assessment.

Purpose of the Study:

  • To investigate biochemical determinants of chemical-induced embryonic growth alterations.
  • To compare direct effects of steroidal and nonsteroidal estrogens on cultured rat embryos.
  • To assess the influence of biotransformation on chemical embryotoxicity.

Main Methods:

  • Cultured whole rat embryos exposed to various steroidal and nonsteroidal estrogens and phenols.
  • Concentrations used produced measurable embryotoxicity with low embryolethality.
  • Inclusion of a cytochrome P450-dependent oxidizing system in the culture medium to study biotransformation.

Main Results:

  • Prosencephalic hypoplasia was a consistent abnormality induced by all tested chemicals.
  • Embryotoxicity was not related to estrogenic potency or steroidal structure.
  • Biotransformation significantly and unpredictably influenced embryotoxicity, with varying effects depending on the chemical and the presence of a metabolic system.

Conclusions:

  • Chemical effects on early organogenesis are independent of steroid structure or estrogenic activity.
  • Embryotoxicity is strongly dependent on the pathways and rates of chemical biotransformation.
  • Cytochrome P450 metabolism plays a critical role in modulating the developmental toxicity of certain chemicals.

More Related Videos

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox00:05

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation09:49

Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation

Published on: October 31, 2019

Related Concept Videos

Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
Drug Biotransformation: Overview01:28

Drug Biotransformation: Overview

Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs01:21

Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in determining the metabolic...
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...